IMR Press / FBE / Volume 1 / Issue 1 / DOI: 10.2741/E25

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

BCL-2: pro-or anti-oxidant?
Show Less
1 Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
2 NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore
3 Duke-NUS Graduate Medical School, Singapore
4 Singapore-MIT Alliance, Singapore
Front. Biosci. (Elite Ed) 2009, 1(1), 263–268;
Published: 1 June 2009

Bcl-2 is recognized as an oncoprotein via its ability to impede death signaling by sequestrating pro-apoptotic proteins such as Bax and Bak as well as preserving mitochondrial outer membrane integrity. Recently, a growing body of evidence has evaluated the role of Bcl-2 in intracellular redox regulation and its downstream effects on life and death decisions in cancer cells. On the backdrop of these findings, we discuss here the classical anti-apoptotic role of Bcl-2 in malignant cells, and review the significance of Bcl-2-mediated regulation of tumor redox status. We discuss recent evidence that underscores a paradigm shift in the way cellular redox status impacts cell fate decisions via the effect of Bcl-2 on mitochondrial physiology. The ability of Bcl-2 to promote, modulate and optimize mitochondrial respiration under different redox states highlights the importance of mitochondrial bioenergetics, ROS and the roles they might play in the onset and/or maintenance of oncogenesis.

Back to top